Omnicell Reports Results for Second Quarter 2019
Omnicell, Inc. (OMCL)
Last omnicell, inc. earnings: 2/6 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.omnicell.com
Company Research
Source: Business Wire
Record GAAP and non-GAAP revenues of $217.4 million, up 15.2% year-over-yearGAAP net income per diluted share of $0.37, up 131.3% year-over-yearNon-GAAP net income per diluted share of $0.67, up 45.7% year-over-year MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its second quarter ended June 30, 2019.GAAP ResultsGAAP revenues for the second quarter of 2019 were $217.4 million, up $28.7 million, or 15.2% from the second quarter of 2018. GAAP revenues for the six months ended June 30, 2019 were $419.9 million, up $48.6 million, or 13.1%, from the six months ended June 30, 2018.Second quarter 2019 GAAP net income as reported was $16.0 million, or $0.37 per diluted share. This compares to GAAP net income of $6.6 million, or $0.16 per diluted share, for the second quarter of 2018.GAAP net income for the six months ended June
Show less
Read more
Impact Snapshot
Event Time:
OMCL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OMCL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OMCL alerts
High impacting Omnicell, Inc. news events
Weekly update
A roundup of the hottest topics
OMCL
News
- Wall Street Analysts Believe Omnicell (OMCL) Could Rally 26.73%: Here's is How to Trade [Yahoo! Finance]Yahoo! Finance
- Omnicell, Inc. (NASDAQ: OMCL) had its price target raised by analysts at JPMorgan Chase & Co. from $37.00 to $44.00. They now have a "neutral" rating on the stock.MarketBeat
- The Healthcare Technology Report Announces The Top 100 Healthcare Technology Companies of 2024PR Web
- Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering [Yahoo! Finance]Yahoo! Finance
- Omnicell Announces Pricing of $150 Million Convertible Senior Notes OfferingBusiness Wire
OMCL
Earnings
- 10/30/24 - Beat
OMCL
Sec Filings
- 11/19/24 - Form 4
- 11/19/24 - Form 4
- 11/19/24 - Form 4
- OMCL's page on the SEC website